Corticosteroids act by binding to intracellular glucocorticoid receptors, suppressing inflammatory pathways and modulating neuronal excitability through inhibition of pro-inflammatory cytokines and reduction of neurogenic inflammation. In Visual Snow Syndrome, they may potentially mitigate cortical hyperexcitability and neuroinflammatory processes, though their efficacy remains an area of ongoing research with limited definitive clinical evidence.